Answers are grounded in this paper and cite their sources.
hMSC therapy decreased E. coli induced pneumonia injury and reduced lung bacterial burden, potentially via enhanced macrophage phagocytosis and increased alveolar LL-37 concentrations.
No takes yet. Share an insight, caveat, or question.
Devaney et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: